The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: The untold story
Anton Skaro(Comprehensive Clinical Research), Michaël Abécassis(University of Arizona), Luke Preczewski(Miami Transplant Institute), Colleen L. Jay(Northwestern University), Edward Wang, Sarina Pasricha(University of North Carolina at Chapel Hill), John A. Martin(Mayo Clinic), Talia Baker(University of Utah), Joseph Feinglass(Northwestern University), Vadim Lyuksemburg(Comprehensive Clinical Research)
Cited by 187
Related Papers
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k
The International Position on Laparoscopic Liver Surgery
|Annals of Surgery|2009|1.5k
Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors
|Liver Transplantation|2010|1.2k